Skip to main content
CELU
NASDAQ Life Sciences

Celularity Receives Nasdaq Delisting Notice for Failing $35M Market Value Requirement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.713
Mkt Cap
$20.636M
52W Low
$0.667
52W High
$4.35
52W Position info
6.9% above low
Off High info
84% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CELU is trading near its 52-week low of $0.667 (6.9% above the low) on light trading volume (0.3× avg).

Summary

Celularity Inc. faces potential delisting from Nasdaq after failing to meet the $35 million minimum Market Value of Listed Securities requirement, with a compliance deadline of December 7, 2026.


Key Events · Legal and Risk Events · CELU

  • Delisting Notice Received

    Celularity Inc. received a notice from Nasdaq on June 9, 2026, for non-compliance with the minimum Market Value of Listed Securities (MVLS) rule.

  • Non-Compliance Reason

    The company's MVLS has been below the required $35 million for 30 consecutive business days.

  • Compliance Deadline

    Celularity has 180 calendar days, until December 7, 2026, to regain compliance by having its MVLS meet or exceed $35 million for at least 10 consecutive business days.

  • Potential Actions

    The company is evaluating options to regain compliance, including monitoring its market value and potentially increasing stockholders' equity.


Analysis · CELU · Life Sciences

Celularity Inc. has received a notice from Nasdaq indicating non-compliance with the minimum Market Value of Listed Securities (MVLS) requirement. The company's MVLS has been below $35 million for 30 consecutive business days. This is a critical development as failure to regain compliance by December 7, 2026, could lead to delisting, significantly impacting the company's ability to raise capital and investor confidence.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CELU was trading at $0.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.6M. The 52-week trading range was $0.67 to $4.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CELU - Latest Insights

CELU
Nov 10, 2026, 4:30 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $0.451 info
Change: -$0.269 (-37%) info
Market Cap: $15.025M info
CELU
Oct 28, 2026, 5:52 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.451 info
Change: -$0.529 (-54%) info
Market Cap: $15.025M info
CELU
Oct 20, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.451 info
Change: -$0.809 (-64%) info
Market Cap: $15.025M info
CELU
Oct 05, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $0.451 info
Change: -$1.16 (-72%) info
Market Cap: $15.025M info
CELU
Sep 29, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.39
Real-time Price: $0.451 info
Change: -$0.939 (-68%) info
Market Cap: $15.025M info